Eukaryotic expression vectors resistant to transgene silencing
The present invention relates to recombinant DNA molecules such as plasmids, non-viral vectors, viral vectors and hybrids thereof, and more particularly to vector modifications that improve expression of said DNA molecules in cell lines and organisms.
1. A method of improving the duration of transgene expression, the method comprising: a) providing an expression vector comprising a prokaryotic replication origin, a selectable marker, a eukaryotic expression cassette and tRNA promoters upstream and downstream of the eukaryotic expression cassette, said tRNA promoters each comprising the two intragenic promoter elements RNA pol III type II promoter A-box and B-box, said tRNA promoters preventing gene silencing, said eukaryotic expression cassette comprising the transgene under the control of a heterologous promoter; and b) introducing said expression vector into a target vertebrate cell or a vertebrate organism comprising the target vertebrate cells, under conditions wherein the target vertebrate cells are transfected and said transgene is expressed, wherein the duration of transgene expression is greater than achieved with the same vector lacking said tRNA promoters upstream and downstream of the eukaryotic expression cassette.
2. The method of claim 1 , wherein said tRNA promoters comprise the human tRNA valine promoter nucleic acid sequence of SEQ ID NO:2.
3. The method of claim 1 , wherein said vector is selected from the group consisting of: a non-viral vector, a viral vector, an integrating vector, a non-integrating vector, and a plasmid.
4. A method of improving the duration of transgene expression, the method comprising: a) providing an expression vector comprising a prokaryotic replication origin, an antibiotic-free selectable marker, a eukaryotic expression cassette and tRNA promoters upstream and downstream of the eukaryotic expression cassette, said tRNA promoters each comprising the two intragenic promoter elements RNA pol III type II promoter A-box and B-box, said tRNA promoters preventing, gene silencing, said eukaryotic expression cassette comprising the transgene under the control of a heterologous promoter; and
b) linearizing, said vector in the vector backbone; and
c) introducing said expression vector into a target vertebrate cell or a vertebrate organism comprising the target vertebrate cells, under conditions wherein the target vertebrate cells are transfected and said transgene is expressed, wherein the duration of transgene expression is greater than achieved with the same vector lacking said tRNA promoters upstream and downstream of the eukaryotic expression cassette.
5. The method of claim 4 , wherein said vector is selected from the group consisting of: a non-viral vector, a viral vector, an integrating vector, a non-integrating vector, and a plasmid.
6. The method of claim 4 , wherein said tRNA promoters comprise the human tRNA valine promoter nucleic acid sequence of SEQ ID NO:2.
7. A method of improving the duration of transgene expression, the method comprising: a) providing an expression vector comprising a prokaryotic replication origin, an antibiotic-free selectable marker, a eukaryotic expression, cassette and tRNA promoters upstream and downstream of the eukaryotic expression cassette, wherein said tRNA promoters comprise the human tRNA valine promoter nucleic acid sequence of SEQ NO:2, said tRNA promoters preventing gene silencing, said eukaryotic expression cassette comprising i) the transgene under the control of a heterologous promoter; and
b) introducing said expression vector into a target vertebrate cell or a vertebrate organism comprising the target vertebrate cells, under conditions wherein the target vertebrate cells are transfected and said transgene is expressed, wherein the duration of transgene expression is greater than achieved with the same vector lacking, said tRNA promoters upstream and downstream of the eukaryotic expression cassette.